Leica Biosystems Nussloch GmbH Sustainability Profile
Leica Biosystems Nussloch GmbH, a prominent player in the life sciences sector, is headquartered in Nussloch, Germany. Founded in 1869, the company has established itself as a leader in the development of innovative pathology solutions, serving healthcare professionals across Europe and beyond. Specialising in histopathology, Leica Biosystems offers a comprehensive range of products and services, including advanced imaging systems, tissue processing equipment, and diagnostic tools. Their commitment to quality and precision sets them apart in the industry, ensuring that laboratories can deliver accurate results efficiently. With a strong market position, Leica Biosystems is recognised for its contributions to cancer diagnostics and research, continually pushing the boundaries of technology to enhance patient care. The company’s dedication to innovation and excellence has earned it numerous accolades, solidifying its reputation as a trusted partner in the medical community.
DitchCarbon Score
How does Leica Biosystems Nussloch GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Leica Biosystems Nussloch GmbH's score of 59 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Leica Biosystems Nussloch GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Danaher Corporation, any climate commitments or emissions data would be inherited from this parent company. Danaher Corporation has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Leica Biosystems Nussloch GmbH are not detailed in the available information. As part of its commitment to sustainability, Leica Biosystems Nussloch GmbH aligns with the broader climate strategies of Danaher Corporation, which focuses on reducing emissions across its operations. This includes efforts to address Scope 1, 2, and 3 emissions, although specific figures for these scopes are not provided for Leica Biosystems Nussloch GmbH. In summary, while Leica Biosystems Nussloch GmbH is part of a corporate family with established climate commitments, specific emissions data and reduction targets for the company itself are currently unavailable.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 138,341,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 219,166,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
How Carbon Intensive is Leica Biosystems Nussloch GmbH's Industry?
How Carbon Intensive is Leica Biosystems Nussloch GmbH's Location?
Leica Biosystems Nussloch GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Leica Biosystems Nussloch GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
